Verisign Inc/ca Form 4 insider transactions

NASDAQ
VeriSign's EVP and CFO, John Calys, reported the disposition of common stock to cover tax liabilities related to restricted stock unit vesting.
NASDAQ
VeriSign's Executive Chairman, President, and CEO, D. James Bidzos, disposed of common stock valued at $252.88 per share to cover tax liabilities related to restricted stock unit vesting.
NASDAQ
VeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 9,900 shares of common stock for approximately $2.47 million between November 11 and November 13, 2025, as part of a pre-arranged 10b5-1 trading plan.
NASDAQ
A VeriSign executive sold 668 shares of common stock in pre-planned transactions, reducing beneficial ownership.
NASDAQ
VeriSign's EVP and Chief Financial Officer, John Calys, reported the sale of 1,001 shares of common stock for approximately $242,954, executed under a Rule 10b5-1 plan.
NASDAQ
A VeriSign executive sold 334 shares of common stock for $244.52 per share, reducing their direct beneficial ownership to 33,855.2718 shares.
NASDAQ
VeriSign's EVP of Technology & CSO, Danny R. McPherson, sold 2,500 shares of common stock for approximately $592,175 under a pre-arranged Rule 10b5-1 plan.
NASDAQ
VeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 8,900 shares of common stock over three days in October 2025, pursuant to a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
VeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 9,000 shares of common stock over three days in October 2025, pursuant to a Rule 10b5-1 trading plan.
NASDAQ
VeriSign's EVP of Technology & CSO, Danny R. McPherson, disposed of 26.3361 shares of common stock to cover tax liabilities related to restricted stock unit vesting.
NASDAQ
VeriSign's EVP, General Counsel & Secretary, Thomas C. Indelicarto, reported the sale of 501 shares of common stock for $262.92 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
VeriSign's EVP, General Counsel & Secretary, Thomas C. Indelicarto, sold 501 shares of common stock for $270.87 per share under a pre-arranged trading plan.
NASDAQ
VeriSign Director Matthew J. Desch received an award of 728 restricted stock units, which vested immediately upon grant.
NASDAQ
VeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 2,000 shares of common stock through a Rule 10b5-1 plan.
NASDAQ
VeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold a total of 7,000 shares of common stock in multiple transactions on September 16 and 17, 2025, under a Rule 10b5-1 trading plan.
NASDAQ
VeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold a total of 8,750 shares of common stock over several transactions in early September 2025 under a Rule 10b5-1 plan.
NASDAQ
VeriSign's EVP, General Counsel & Secretary, Thomas C. Indelicarto, sold 501 shares of common stock for $282.28 per share under a pre-arranged 10b5-1 plan.
NASDAQ
VeriSign's EVP, General Counsel & Secretary, Thomas C. Indelicarto, sold 501 shares of common stock for $270.46 per share under a pre-arranged 10b5-1 plan.
NASDAQ
VeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 9,000 shares of common stock for approximately $2.4 million over three days in August 2025, pursuant to a Rule 10b5-1 plan.
NASDAQ
VeriSign Director Timothy Tomlinson reported the sale of 700 shares of common stock at $270 per share, executed under a pre-arranged 10b5-1 plan.
NASDAQ
VeriSign's EVP and CFO, John Calys, disposed of shares to cover tax liabilities related to restricted stock unit vesting.
NASDAQ
A VeriSign executive disposed of common stock shares to cover tax liabilities related to the vesting of restricted stock units.
NASDAQ
VeriSign's EVP of Technology and CSO, Danny R. McPherson, disposed of shares valued at approximately $168,121 to cover tax liabilities from restricted stock unit vesting.
NASDAQ
VeriSign's Executive Chairman, President, and CEO, D. James Bidzos, reported the disposition of shares to cover tax liabilities related to restricted stock unit vesting.
NASDAQ
VeriSign's Executive Chairman, President, and CEO, D. James Bidzos, sold 9,000 shares of common stock for approximately $2.34 million through a pre-arranged 10b5-1 plan.
NASDAQ
VeriSign's EVP, General Counsel & Secretary, Thomas C. Indelicarto, sold 501 shares of common stock for $264.5 per share as part of a pre-arranged trading plan.
NASDAQ
VeriSign's EVP, General Counsel, and Secretary, Thomas C. Indelicarto, sold 501 shares of common stock for approximately $135,000 under a Rule 10b5-1 trading plan.
NASDAQ
Berkshire Hathaway Inc. and Warren E. Buffett reported the sale of 4.3 million shares of VeriSign Inc. common stock for approximately $1.21 billion, effective July 30, 2025.
NASDAQ
VeriSign Inc. Director Debra McCann received an award of 879 restricted stock units, which vested immediately upon grant on July 21, 2025.
NASDAQ
VeriSign Director Courtney D. Armstrong received an award of 879 restricted stock units, vesting immediately on July 21, 2025.